Other: Clinical Trials

3 trials of Other, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 terminated. 3 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 2, Terminated 1
Phase 21Terminated 1

Follow Other: new trials by email Literature Review of Other trials Research Report on Other

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate the Effects of D-1553 on PK of Midazolam, Caffeine, Rosuvastatin, Furosemide, Digoxin, and Itraconazole or Omeprazole on PK of D-1553
D-1553 - Healthy Male
Phase 1CompletedInventisBio Co., Ltd452023-05-242024-10-15
A Study to Evaluate D-1553 in Combination Therapy in Non-Small Cell Lung Cancer
D-1553, Other - NSCLC
Phase 1 / Phase 2TerminatedInventisBio Co., Ltd222022-09-132024-10-15
Vascular Function and Biomarker Assessments in Healthy Volunteers and in Patients With Type 2 Diabetes Mellitus
Other - Type 2 Diabetes Mellitus
Phase 1CompletedInstitut de Recherches Internationales Servier1002017-04-032024-07-25

Conditions studied

Cardiovascular Diseases (1)  ·  Diabetes Mellitus, Type 2 (1)

Sponsors

InventisBio Co., Ltd (2)  ·  Institut de Recherches Internationales Servier (1)

Countries

China (2)  ·  Germany (1)

Top investigators

Denis Strugala, Dr (1)

NIH funding

2017 (1)